BNF:

9.1.3

Status:

Do Not Prescribe (DNP), Red

Decision Date:

February 2015

Comments

RED: NICE HST1: for treating atypical haemolytic uraemic syndrome.

DO NOT PRESCRIBE (DNP)⁶: NICE TA636 - refractory myasthenia gravis (terminated appraisal) (Decision date - July 2020)

DO NOT PRESCRIBE (DNP): NICE TA647 - relapsing neuromyelitis optica (terminated appraisal) (Decision date - October 2020) 

Do Not Prescribe (DNP) Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
• 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)

search again